The human dihydropyrimidinase-related protein 2 (DRP-2) gene on chromosome 8p21 is associated with paranoid-type schizophrenia

Japanese Journal of Neuropsychopharmacology

Volumn 24, Issue 1, 2004, Pages 33-37

  Nakata, Kenji ^a,b   Ujike, Hiroshi ^a  

^a OKAYAMA UNIVERSITY   (Japan)

^b Tottori Municipal Hospital   (Japan)

Author keywords

Association study; Chromosome 8p21; CRMP 2; DRP 2; Schizophrenia

Indexed keywords

COLLAPSIN RESPONSE MEDIATOR PROTEIN; PROTEIN; SEMAPHORIN; UNCLASSIFIED DRUG;

ALLELE; CHROMOSOME 8P; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE PREDISPOSITION; DRP 2 GENE; GENE; GENE MUTATION; GENETIC LINKAGE; GENETIC POLYMORPHISM; GENETIC SUSCEPTIBILITY; GENOTYPE; HUMAN; MAJOR CLINICAL STUDY; NEUROPATHOLOGY; PARANOID SCHIZOPHRENIA; PATHOGENESIS; SHORT SURVEY;

ALLELES; CHROMOSOMES, HUMAN, PAIR 8; GENE FREQUENCY; GENETIC PREDISPOSITION TO DISEASE; HUMANS; INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS; LINKAGE DISEQUILIBRIUM; MUTATION; NERVE TISSUE PROTEINS; POLYMORPHISM, GENETIC; PROTEINS; SCHIZOPHRENIA, PARANOID;

EID: 1642544717     PISSN: 13402544     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Short Survey

References (39)

1. Bailer, U., Leisch, K., Meszaros, K., Lenzinger, E., Willinger, U., Strobl, R., Heiden, A., Gebhardt, C., Doge, E., Fuchs, K., Sieghart, W., Kasper, S., Hornik, K. and Ashauer, H. N. (2002) Genome scan for susceptibility loci for schizophrenia and bipolar disorder. Biol Psychiatry, 52: 40-52.
2. Blouin, J.-L., Dombroski, B. A., Nath, S. K., Lasseter, V. K., Wolyniec, P. S. and Nestadt, G. (1998) Schizophrenia susceptibility loci on chromosomes 13q32 and 8p21. Nat Genet, 20: 70-73.
3. Byk, T., Dobransky, T., Cifuentes-Diaz, C. and Sobel, A. (1996) Identification and molecular characterization of unc-33-like phosphoprotein (Ulip), a putative mammalian homolog of the axonal guidance-associated unc-33 gene product. J Neurosci, 16: 688-701.
4. Cannon, T. D., Kaprio, J., Lonnqvist, J., Huttunen, M. and Koskenvuo, M. (1998) The genetic epidemiology of schizophrenia in a Finnish twin cohort. A population-based modeling study. Arch Gen Psychiatry, 55: 67-74.
5. Chen, G., Rajkowska, G., Du, F., Seraji-Bozorgzad, N. and Manji, H. K. (2000) Enhancement of hippocampal neurogenesis by lithium. J Neurochem, 75: 1729-1734.
6. Cichon, S., Schumacher J., Muller, D. J., Hurter, M., Windemuth, C., Strauch, K., Hemmer, S., Schulze, T. G., Schmidt-Wolf, G., Albus, M., Borrmann-Hassenbach, M., Franzek, E., Lanczik, M., Fritze, J., Kreiner, R., Reuner, U., Weigelt, B., Minges, J., Lichtermann, D., Lerer, B., Kanyas, K., Baur, M. P., Wienker, T. F., Maier, W., Rietschel, M., Propping, P. and Nothen, M. M. (2001) A genome screen for genes predisposing to bipolar affective disorder detects a new susceptibility locus on 8q. Hum Mol Genet, 10: 2933-2944.
7. Conne, B., Stutz, A. and Vassalli, J. D. (2000) The 3′ untranslated region of messenger RNA: A molecular hotspot for pathology? Nat Med, 6: 637-641.
8. Conrad, A. J. and Scheibel, A. B. (1987) Schizophrenia and the hippocampus: The embryological hypothesis extended. Schizophr Bull, 13: 577-587.
9. Day, D. A. and Tuite, M. F. (1998) Post-transcriptional gene regulatory mechanisms in eukaryotes: An overview. J Endocrinol, 157: 361-371.
10. Decker, C. J. and Parker, R. (1995) Diversity of cytoplasmic functions for the 3′untranslated region of eukaryotic transcript. Curr Opin Cell Biol, 7: 386-392.
11. Duman, R. S. (2002) Synaptic plasticity and mood disorders. Mol Psychiatry, 7: S29-S34.
12. Fukata, Y., Kimura, T. and Kaibuchi, K. (2002) Axon specification in hippocampal neurons. Neurosci Res, 43: 305-315.
13. Goshima, Y., Nakamura, F., Strittmatter, P. and Strittmatter, S. M. (1995) Collapsin-induced growth cone collapse mediated by an intracellular protein related to UNC-33. Nature, 376: 509-514.
14. Gurling, H. M. D., Kalsi, G., Brynjolfson, J., Sigmundsson, T., Sherrington, R., Mankoo, B. S., Read, T., Murphy, P., Blaveri, E., McQuillin, A., Petursson, H. and Curtis, D. (2001) Genomewide genetic linkage analysis confirms the presence of susceptibility loci for schizophrenia, on chromosomes 1q32.2, 5q33.2, and 8p21-22 and provides support for linkage to schizophrenia, on chromosomes 11q23.3-24 and 20q12.1-11.23. Am J Hum Genet, 68: 661-673.
15. Hamajima, N., Matsuda, K., Sakata, S., Tamaki, N., Sasaki, M. and Nonaka, M. (1996) A novel gene family defined by human dihydropyrimidinase and three related proteins with differential tissue distribution. Gene, 180: 157-163.
16. Henderson, M. J., Ward, K., Simmonds, H. A., Duley, J. A. and Davies, P. M. (1993) Dihydropyrimidinase deficiency presenting in infancy with severe developmental delay. J Inherit Metab Dis, 16: 574-576.
17. Jackson, R.J. (1993) Cytoplasmic regulation of mRNA function: The importance of the 3′untranslated region. Cell, 74: 9-14.
18. Johnston-Wilson, N. L., Sims, C. D., Hofmann, J. P., Anderson, L., Shore, A. D., Torrey, E. F., Yolken, R. H. and the Stanley Neuropathology Consortium (2000) Disease-specific alterations in frontal cortex brain proteins in schizophrenia, bipolar disorder, and major depressive disorder. Mol Psychiatry, 5: 142-149.
19. Kendler, K. S., Myers, J. M., O'Neill, F. A., Martin, R., Murphy, B., MacLean, C. J., Walsh, D. and Straub, R. E. (2000) Clinical features of schizophrenia and linkage to chromosomes 5q, 6p, 8p, and 10p in the Irish study of high-density schizophrenia families. Am J Psychiatry, 157: 402-408.
20. Koyama, K., Sudo, K. and Nakamura, Y. (1995) Isolation of 115 human chromosome 8-specific expressed-sequence tags by exon amplification. Genomics, 26: 245-253.
21. Lubec, G., Nonaka, M., Krapfenbauer, K., Gratzer, M., Cairns, N. and Fountoulakis, M. (1999) Expression of the dihydropyrimidinase related protein 2 (DRP-2) in Down Syndrome and Alzheimer's disease brain is downregulated at the mRNA and dysregulated at the protein level. J Neural Transm (Suppl), 57: 161-177.
22. Luo, Y., Raible, D. and Raper, J. (1993) Collapsin: A protein in brain that induces the collapse and paralysis of neuronal growth cone. Cell, 75: 217-227.
23. Minturn, J. E., Fryer, H. J. L., Geschwind, D. H. and Hockfield, S. (1995) TOAD-64, a gene expressed early in neuronal differentiation in the rat, is related to unc-33, a C. elegans gene involved in axon outgrowth. J Neurosci, 15: 6757-6766.
24. Murray, R. M. (1994) Neurodevelopmental schizophrenia: The rediscovery of dementia praecox. Br J Psychiatry (Suppl), 25: 6-12.
25. Nakata, K., Ujike, H., Sakai, A., Takaki, M., Imamura, T., Tanaka, Y. and Kuroda, S. (2003a) The human dihydropyrimidinase-related protein 2 (DRP-2) gene on chromosome 8p21 is associated with paranoid-type schizophrenia. Biol Psychiatry, 53: 571-576.
26. Nakata, K., Ujike, H., Takaka, Y., Takaki, M., Sakai, A., Nomura, A., Katsu, T., Uchida, N., Imamura, T., Fujiwara, Y., Hamamura, T. and Kuroda, S. (2003b) No association between the dihydropyrimidinase-related protein2 (DRP-2) gene and bipolar disorder in humans. Neurosci Lett, 349: 171-174.
27. Rao, D. C., Morton, N. E., Gottesman, I. I. and Lew, R. (1981) Path analysis of qualitative data on pairs of relatives: Application to schizophrenia. Hum Hered, 31: 325-333.
28. Pulver, A. E., Lasseter, V. K., Kasch, L., Wolyniec, P., Nestadt, G. and Blouin, J. L. (1995) Schizophrenia: A genome scan targets chromosomes 3p and 8p as potential sites of susceptibility genes. Am J Med Genet, 60: 252-260.
29. Putman, C. W., Rotteveel, J. J., Wevers, R. A., van Gennip, A. H., Bakkeren, J. A. and De Abreu, R. A. (1997) Dihydropyrimidinase deficiency, a progressive neurological disorder? Neuropediatrics, 28: 106-110.
30. Sartorius, N., Jablensky, A., Korten, A., Ernberg, G., Anker, M. and Cooper, J. E. (1986) Early manifestations and first-contact incidence of schizophrenia in different cultures. Psychol Med, 16: 909-928.
31. Stefansson, H., Sigurdsson, E., Steinthorsdottir, V., Bjornsdottir, S., Sigmundsson, T., Ghosh, S., Bryniolfsson, J., Gunarsdottir, S., Ivarsson, O., Chou, T. T., Hialtason, O., Birgisdottir, B., Jonsson, H., Gudnadottir, V. G., Gudmundsdottir, E., Bjornsson, A., Inqvarsson, B. and Stefansson, K. (2002) Neuregulin 1 and susceptibility to schizophrenia. Am J Hum Genet, 71: 877-892.
32. Waddington, J. L., Lane, A., Scully, P. J., Larkin, C. and O'Callaghan, E. (1998) Neurodevelopmental and neuroprogressive processes in schizophrenia. Antithetical or complementary, over a lifetime trajectory of disease? Psychiatr Clin North Am, 21: 123-149.
33. Wang, L. H., Strittmatter, S. M. (1996) A family of rat CRMP genes is differentially expressed in the nervous system. J Neurosci, 16: 6197-6207.
34. Weinberger, D. R. (1987) Implication of normal brain development for the pathogenesis of schizophrenia. Arch Gen Psychiatry, 44: 660-669.
35. Weitzoerfer, R., Fountoulakis, M. and Lubec, G. (2001) Aberrant expression of dihydropyrimidinase related protein-2, -3 and -4 in fetal Down Syndrome brain. J Neural Transm (Suppl), 61: 95-107.
36. Wildenauer, D. B., Schwab, S. G., Maier, W. and Detra-Wadleigh, S. D. (1999) Do schizophrenia and affective disorder share susceptibility genes? Schizophr Res, 39: 107-111.
37. Williams, R. S., Cheng, L., Mudge, A. W. and Harwood, A. J. (2002) A common mechanism of action for three mood-stabilizing drugs. Nature, 417: 292-295.
38. Yoshida, H., Watanabe, A. and Ihara, Y. (1998) Collapsin response mediator protein-2 is associated with neurofibrillary tangles in Alzheimer's disease. J Biol Chem, 273: 9761-9768.